Enanta Pharmaceuticals Inc. (ENTA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Enanta Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$11.55
−5.17% today
Market cap
$355M
Overall quality
25/100
Kronos AI 30-day
+2.9%
6 of 8 simulated paths end higher
Enanta Pharmaceuticals Inc. (ENTA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $355M. It trades at $11.55, down 5.17% today. Its overall quality score is 25 out of 100, ranked against the whole US market. 1 analysts' average target of $20.00 implies +73.2% from today's price. Kronos AI's 30-day forecast is +2.9% (6 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $20.00 |
| Low – high | $20.00 – $20.00 |
| Analysts | 1 |
| Upside to average | +73.2% |
Kronos AI 30-day forecast
| Expected close | $12.53 (+2.9%) |
| Likely range | −2.3% … +5.4% |
| As of | 2026-10-27 |
6 of 8 simulated paths end higher.
Quality scores
| Profitability | 14 |
| Solvency | 33 |
| Growth | 27 |
| Overall | 25 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.